Replies to post #111734 on Savvy Trades and Investments

[wadegarret]

RN- VNDA vs GERN

I took a quick look at VNDA. Market cap $214M vs GERN $1.6B. Then look at the chart. GERN just went back up to a year high, while VNDA has been doing nothing but tanking- almost 50% from a year ago. Then VNDA just got bad news from the FDA about how their latest supplimental NDA for Hetlioz can't be approved in their current form. https://finance.yahoo.com/news/vanda-vnda-falls-fdas-crl-154700469.html

RN, how can you even compare these two companies. How much in revenues is expected to come in for VNDA, even if their insomnia drug is approved ? Do you realize there are other insomnia drugs out there ? GERN will have one of only two drugs in the entire world for a deadly anemia MDS(which turns into leukemia), and is expected to share a $4B+/year market with Bristol Myers drug Reblozyl by 2028. GERN by the way has around $400M in cash right now, and no debt.

[RNsidersbuying]

VNDA 4.05 - just sold some April19/$4 calls at .40

[RNsidersbuying]

VNDA 4.88 - Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder

https://ih.advfn.com/stock-market/NASDAQ/vanda-pharmaceuticals-VNDA/stock-news/93593630/vanda-pharmaceuticals-fanapt-iloperidone-receives